Experimental ALS drug

Name: Experimental ALS drug
Uploaded: 2022-09-08T21:55:15Z
Duration: 2 min 37 s
Description: Dr. Devi Nampiaparampil comments on the news that a panel of FDA health advisers voted to recommend approval for an experimental drug from Amylyx Pharma to treat amyotrophic lateral sclerosis, also known as Lou Gehrig's disease.

Dr. Devi Nampiaparampil comments on the news that a panel of FDA health advisers voted to recommend approval for an experimental drug from Amylyx Pharma to treat amyotrophic lateral sclerosis, also known as Lou Gehrig's disease.

Posted September 8, 2022 5:55pm EDT